Astrana Health, Inc.ASTHEarnings & Financial Report
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Revenue
$486.3M
Gross Profit
N/A
Operating Profit
$30.1M
Net Profit
$19.2M
Gross Margin
N/A
Operating Margin
6.2%
Net Margin
3.9%
YoY Growth
39.6%
EPS
$0.40
Financial Flow
Astrana Health, Inc. Q2 2024 Financial Summary
Astrana Health, Inc. reported revenue of $486.3M (up 39.6% YoY) for Q2 2024, with a net profit of $19.2M (up 45.6% YoY) (3.9% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $486.3M |
|---|---|
| Net Profit | $19.2M |
| Gross Margin | N/A |
| Operating Margin | 6.2% |
| Report Period | Q2 2024 |
Revenue Breakdown
Astrana Health, Inc. Q2 2024 revenue of $486.3M breaks down across 7 segments, led by Medicare at $243.1M (50.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Medicare | $243.1M | 50.0% |
| Medicaid | $180.3M | 37.1% |
| Health Care Patient Service | $20.0M | 4.1% |
| Other Third Parties | $18.6M | 3.8% |
| Health Care Other | $18.4M | 3.8% |
| Other | $3.7M | 0.8% |
| Management Service | $1.6M | 0.3% |
Astrana Health, Inc. Revenue by Segment — Quarterly Trend
Astrana Health, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Medicare and Medicaid) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Medicare | $542.4M | $571.4M | $403.1M | $389.4M |
| Medicaid | — | $244.6M | $192.6M | — |
| Health Care Patient Service | $39.8M | $40.1M | $17.9M | $14.9M |
| Other Third Parties | $58.0M | $55.5M | $13.0M | $11.8M |
| Health Care Other | $25.5M | $30.8M | $15.4M | $14.5M |
Astrana Health, Inc. Annual Revenue by Year
Astrana Health, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $3.2B |
| 2024 | $2.0B |
| 2023 | $1.4B |
| 2022 | $1.1B |
Astrana Health, Inc. Quarterly Revenue & Net Profit History
Astrana Health, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $950.5M | +42.9% | $6.6M | 0.7% |
| Q3 2025 | $956.0M | +99.7% | $373.0K | 0.0% |
| Q2 2025 | $654.8M | +34.7% | $9.4M | 1.4% |
| Q1 2025 | $620.4M | +53.4% | $6.7M | 1.1% |
| Q4 2024 | $665.2M | +88.4% | $-7.8M | -1.2% |
| Q3 2024 | $478.7M | +37.5% | $16.1M | 3.4% |
| Q2 2024 | $486.3M | +39.6% | $19.2M | 3.9% |
| Q1 2024 | $404.4M | +19.9% | $14.8M | 3.7% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $404.4M | $486.3M | $478.7M | $665.2M | $620.4M | $654.8M | $956.0M | $950.5M |
| YoY Growth | 19.9% | 39.6% | 37.5% | 88.4% | 53.4% | 34.7% | 99.7% | 42.9% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.23B | $1.25B | $1.29B | $1.35B | $1.33B | $1.44B | $2.24B | $2.22B |
| Liabilities | $773.9M | $773.8M | $778.3M | $840.7M | $813.5M | $904.4M | $1.68B | $1.66B |
| Equity | $653.5M | $678.9M | $704.6M | $712.7M | $745.4M | $765.5M | $775.5M | $779.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $6.0M | $23.2M | $34.0M | $-10.9M | $16.6M | $90.9M | $10.0M | $-2.9M |